Crinetics Pharmaceuticals, Inc. (CRNX)
47.52
-0.44
(-0.92%)
USD |
NASDAQ |
Dec 29, 16:00
47.79
+0.27
(+0.57%)
After-Hours: 04:52
Crinetics Pharmaceuticals Shareholders Equity (Quarterly): 1.072B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| GT Biopharma, Inc. | 3.00M |
| Sutro Biopharma, Inc. | -87.27M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.196B |
| Total Liabilities (Quarterly) | 123.86M |
| Debt to Equity Ratio | 0.0458 |
| Current Ratio | 15.12 |
| Net Debt Paydown Yield | 0.02% |